Press releases

Edinburgh, United Kingdom; 12th July 2023

Fitabeo Therapeutics appoints Dr Parameswara Rao Vuddanda to lead Technology and Product Development

Dr Parameswara Rao Vuddanda has been appointed as Development Director, to accelerate Technology and Product Development and drive Fitabeo Therapeutics’ quest of delivering innovative medicines

Edinburgh, United Kingdom; 04th May 2023

Fitabeo Therapeutics and ILC Therapeutics join forces to develop novel hybrid interferon-based medicines

Partnership is aimed at accelerating the development of new treatments based on novel hybrid interferons to treat serious, unmet medical needs

Edinburgh, United Kingdom; 10^th February 2023

Fitabeo Therapeutics and Pharmanovia enter strategic partnership to improve the patient experience of two of its established medicines

Partnership will explore treatment adherence and overall health outcomes for patients for established medicines in the Pharmanovia range, using innovative technology designed by Fitabeo Therapeutics

Edinburgh, United Kingdom; 12^th December 2022

Fitabeo Therapeutics launches with the goal to provide solutions for pressing healthcare challenges. Appoints industry veteran Jodi Devlin as Chair

Fitabeo Therapeutics has ‘spun-out’ from the University of Strathclyde with ambitious plans to address some of society’s most pressing healthcare challenges within chronic pain and women’s health. It also announces the appointment of accomplished pharmaceutical executive Jodi Devlin as Chair of the Board.